20.4 C
New York
Saturday, September 18, 2021

Wall Street’s Key Stock Analysts Research Report


Daily HeffX-LTN reviews dozens of  Wall Street’s Key analysts research reports to ID new trading and investing ideas for HeffX-LTN readers. Some reports cover stocks to buy, and others cover stocks to sell or avoid.

Below is the list for Monday, 2 March, as follows;

Bed Bath & Beyond Inc. (NASDAQ:BBBY) reiterated as Outperform with an $18 target price at Wedbush Securities, with the firm saying its restructuring plan with another 10% of staff cuts is an important step forward in its turnaround.

Continental Resources Inc. (NYSE:CLR) was maintained as Buy but the target price was lowered to 35 from 41 at MKM Partners.

Crown Castle International Corp. (NYSE:CCI): Wells Fargo reiterated its Overweight rating and raised its target price to 165 from 156.

Denali Therapeutics Inc. (NASDAQ:DNLI) was raised to Outperform from Neutral with a 24 target price at Wedbush.

Harpoon Therapeutics Inc. (NASDAQ:HARP) was started as Buy with a 31 target price at SunTrust, effectively giving it more than 100% implied Northside despite the market sell-off.

Trade Desk Inc. (NASDAQ:TTD) was reiterated as Buy with a 305 target price at SunTrust. Wells Fargo raised it to Overweight from Equal Weight with a 310 target price

Uber Technologies Inc. (NYSE:UBER) KeyBanc Capital Markets started Uber as Overweight with a 48 target price.

Have a terrific week

HEFFX has become one of Asia’s leading financial services companies with interests in Publishing, Private Equity, Capital Markets, Mining, Retail, Transport and Agriculture that span every continent of the world. Our clearing partners have unprecedented experience in Equities, Options, Forex and Commodities brokering, banking, physical metals dealing, floor brokering and trading.

Related Articles

Stay Connected

- Advertisement -spot_img

Latest Articles